CAI
Caris Life Sciences, Inc.
28.30$
-0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 47.8% | 45.0% | -0.4% | 33.0% | 47.2% | 54.5% | 57.4% | 61.4% | 58.5% | 61.4% | 59.0% | 43.9% | 44.5% | 41.6% | 61.0% | 94.2% | -110.5% | -90.2% | -59.5% | 10.2% | |
| 31.9% | 23.3% | 24.1% | 15.4% | 16.6% | 21.1% | 29.0% | 28.8% | 28.1% | 28.6% | 32.2% | 34.6% | 45.8% | 36.2% | 32.5% | 28.6% | 27.4% | 37.6% | 18.7% | 16.0% | 11.9% | 2.8% | |
| – | – | – | – | – | 1.2% | 1.5% | 1.4% | 0.9% | 0.7% | 0.7% | 0.8% | 0.8% | 0.6% | 0.6% | 0.7% | 0.7% | 0.6% | 8.9% | 5.0% | 4.5% | 8.6% | |
| – | – | -5.8% | -77.7% | 22.9% | 46.9% | -16.6% | -141.8% | 64.7% | -4.3% | -6.7% | -34.5% | 12.3% | 15.3% | -26.0% | -19.9% | 100.2% | -107.9% | -8.6% | -2.3% | -7.1% | -4.1% | |
| 126.2% | 188.5% | 0.6% | 246.4% | 338.6% | 245.7% | 48.0% | 265.5% | 391.3% | 301.6% | 147.0% | 135.0% | 156.0% | 85.4% | 144.1% | 188.1% | 76.6% | 74.6% | 16.3% | 7.3% | 2.0% | 2.0% | |
| -126.2% | -188.5% | -13.4% | 42.1% | -128.0% | -93.3% | 5.7% | -201.8% | -342.2% | -265.2% | -125.6% | -99.0% | -122.3% | -61.7% | -118.2% | -153.5% | -65.3% | -11.6% | -109.5% | 70.2% | 12.8% | -2.0% | |
| – | – | – | – | 1.2% | – | – | – | – | – | – | – | – | – | – | 0.8% | 2.1% | 6.0% | – | – | – | – | |
| – | – | – | -215.5% | – | – | – | – | – | – | – | -13.8% | -5.2% | -3.1% | – | -9.5% | -8.2% | -2.7% | – | 0.0% | 0.0% | 0.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.4% | 3.5% | 48.5% | 3.4% | |
| – | – | -30.9% | -1.5% | 110.0% | 85.0% | -75.1% | 147.7% | 284.8% | 205.9% | 81.0% | 41.8% | 62.7% | 15.8% | 70.5% | 118.6% | -26.0% | -85.0% | 4.0% | 3.3% | 48.6% | 81.9% | |
| -126.2% | -188.5% | 3.3% | 86.5% | -18.4% | 24.2% | -21.5% | -0.1% | -0.3% | 2.1% | 13.2% | 3.6% | -0.5% | -2.2% | -3.1% | 6.7% | -0.7% | -2.3% | -216.0% | -16.7% | 1.9% | 90.1% | |
| -126.2% | -188.5% | 47.2% | -201.4% | -339.0% | -212.7% | -0.9% | -211.1% | -334.0% | -240.2% | -88.5% | -73.7% | -96.9% | -41.4% | -99.6% | -146.5% | -15.6% | 19.6% | -126.9% | -97.5% | -61.5% | 8.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.